by Vimal Aga, MD Dr. Aga is a board-certified geriatric psychiatrist and an Adjunct Assistant Professor of Psychiatry and Neurology at Oregon Health Sciences University in Portland, Oregon. While there are no published randomized, controlled clinical trials of the use of gabapentin for the treatment of neuropsychiatric symptoms in persons with dementia (as of March 2018),…
This content is for Monthly Membership and Yearly Membership members only.
Register
Register
Already a member? Log in here